Pulmonary Hypertension Subtypes and Mortality in CKD

被引:43
作者
Edmonston, Daniel L. [1 ,2 ]
Parikh, Kishan S. [2 ,3 ]
Rajagopal, Sudarshan [3 ,4 ]
Shaw, Linda K. [2 ]
Abraham, Dennis [3 ]
Grabner, Alexander [1 ]
Sparks, Matthew A. [1 ,5 ]
Wolf, Myles [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Dept Med, Div Nephrol, Durham, NC 27706 USA
[2] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA
[4] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
[5] Durham VA Med Ctr, Renal Sect, Durham, NC USA
基金
美国国家卫生研究院;
关键词
CHRONIC KIDNEY-DISEASE; ASYMMETRIC DIMETHYL ARGININE; HEART-FAILURE; ARTERIAL-HYPERTENSION; CARDIOVASCULAR EVENTS; POST-CAPILLARY; NITRIC-OXIDE; OUTCOMES; STAGE; PATHOPHYSIOLOGY;
D O I
10.1053/j.ajkd.2019.08.027
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: Pulmonary hypertension (PH) contributes to cardiovascular disease and mortality in patients with chronic kidney disease (CKD), but the pathophysiology is mostly unknown. This study sought to estimate the prevalence and consequences of PH subtypes in the setting of CKD. Study Design: Observational retrospective cohort study. Setting & Participants: We examined 12,618 patients with a right heart catheterization in the Duke Databank for Cardiovascular Disease from January 1, 2000, to December 31, 2014. Exposures: Baseline kidney function stratified by CKD glomerular filtration rate category and PH subtype. Outcomes: All-cause mortality. Analytical Approach: Multivariable Cox proportional hazards analysis. Results: In this cohort, 73.4% of patients with CKD had PH, compared with 56.9% of patients without CKD. Isolated postcapillary PH (39.0%) and combined pre- and postcapillary PH (38.3%) were the most common PH subtypes in CKD. Conversely, precapillary PH was the most com-mon subtype in the non-CKD cohort (35.9%). The relationships between mean pulmonary artery pressure, pulmonary capillary wedge pressure, and right atrial pressure with mortality were similar in both the CKD and non-CKD cohorts. Compared with those without PH, precapillary PH conferred the highest mortality risk among patients without CKD (HR, 2.27; 95% CI, 2.00-2.57). By contrast, in those with CKD, combined pre- and postcapillary PH was associated with the highest risk for mortality in CKD in adjusted analyses (compared with no PH, HRs of 1.89 [95% CI, 1.57-2.28], 1.87 [95% CI, 1.52-2.31], 2.13 [95% CI, 1.52-2.97], and 1.63 [95% CI, 1.12-2.36] for glomerular filtration rate categories G3a, G3b, G4, and G5/G5D). Limitations: The cohort referred for right heart catheterization may not be generalizable to the general popu lation. Serum creatinine data in the 6 months preceding catheterization may not reflect true baseline CKD. Observational design precludes assumptions of causality. Conclusions: In patients with CKD referred for right heart catheterization, PH is common and associated with poor survival. Combined pre- and postcapillary PH was common and portended the worst survival for patients with CKD
引用
收藏
页码:713 / 724
页数:12
相关论文
共 50 条
  • [41] Use of Thiazides to Treat Hypertension and Advanced CKD
    Priamvada, Gargi Sharma
    Divyadarshini, Divya Sharma
    Voora, Raven
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (12) : 2131 - 2137
  • [42] Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
    Chang, Kevin Y.
    Duval, Sue
    Badesch, David B.
    Bull, Todd M.
    Chakinala, Murali M.
    De Marco, Teresa
    Frantz, Robert P.
    Hemnes, Anna
    Mathai, Stephen C.
    Rosenzweig, Erika Berman
    Ryan, John J.
    Thenappan, Thenappan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (09):
  • [43] Reconsidering α-Blockade for the Management of Hypertension in Patients With CKD
    Ahmad, Sarah
    Neubauer, Adam
    Cohen, Jordana B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (02) : 172 - 174
  • [44] 4D-Flow MRI intracardiac flow analysis considering different subtypes of pulmonary hypertension
    Cain, Michael T.
    Schafer, Michal
    Ross, Lexie K.
    Ivy, David D.
    Mitchell, Max B.
    Fenster, Brett E.
    Bull, Todd M.
    Barker, Alex J.
    Vargas, Daniel
    Hoffman, Jordan R. H.
    PULMONARY CIRCULATION, 2023, 13 (04)
  • [45] Electronic Health Record Patient Portals in CKD and Hypertension Management: Meaningfully Used?
    Mendu, Mallika L.
    Waikar, Sushrut S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (11): : 1897 - 1899
  • [46] A Low Mortality Model of Chronic Pulmonary Hypertension in Sheep
    Pohlmann, Joshua R.
    Akay, Begum
    Camboni, Daniele
    Koch, Kelly L.
    Mervak, Benjamin M.
    Cook, Keith E.
    JOURNAL OF SURGICAL RESEARCH, 2012, 175 (01) : 44 - 48
  • [47] Mortality from Pulmonary Hypertension in the Pediatric Cardiac ICU
    Morell, Emily
    Gaies, Michael
    Fineman, Jeffrey R.
    Charpie, John
    Rao, Rohit
    Sasaki, Jun
    Zhang, Wenying
    Reichle, Garrett
    Banerjee, Mousumi
    Tabbutt, Sarah
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (04) : 454 - 461
  • [48] Mean Corpuscular Volume and Mortality in Patients with CKD
    Hsieh, Yao-Peng
    Chang, Chia-Chu
    Kor, Chew-Teng
    Yang, Yu
    Wen, Yao-Ko
    Chiu, Ping-Fang
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (02): : 237 - 244
  • [49] Systolic BP and Mortality in Older Adults with CKD
    Weiss, Jessica W.
    Peters, Dawn
    Yang, Xiuhai
    Petrik, Amanda
    Smith, David H.
    Johnson, Eric S.
    Thorp, Micah L.
    Morris, Cynthia
    O'Hare, Ann M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (09): : 1553 - 1559
  • [50] Sildenafil, pulmonary hypertension and bronchopulmonary dysplasia
    Herbert, S.
    Tulloh, R.
    EARLY HUMAN DEVELOPMENT, 2016, 102 : 21 - 24